Ask Warren

Yuyu Pharma

000220 · KOSPI · ₩000220 · 유유제약

₩3,650 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩37B₩36B₩34B₩38B₩36B₩33B₩33B₩34B
Cost of sales₩22B₩21B₩22B₩23B₩22B₩19B₩21B₩21B
Gross profit₩15B₩15B₩12B₩15B₩13B₩14B₩12B₩13B
Operating income₩4B₩4.3B−₩129M₩5B₩2.2B₩3.9B−₩268M₩3.5B
Net income₩204M₩3.4B₩4.8B₩3.7B−₩2.4B₩3B₩7B₩1.3B
Net income to shareholders₩3.7B₩3.5B₩1.4B₩4B₩199M₩2.6B−₩735M₩3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩208B₩207B₩207B₩202B₩201B₩210B₩208B₩201B
Current assets₩91B₩95B₩97B₩97B₩96B₩105B₩102B₩106B
Cash and equivalents₩21B₩26B₩29B₩29B₩29B₩42B₩42B₩43B
Total liabilities₩62B₩65B₩67B₩63B₩67B₩74B₩73B₩70B
Current liabilities₩48B₩56B₩59B₩55B₩58B₩65B₩64B₩62B
Borrowings₩5B———————
Total equity₩146B₩143B₩141B₩139B₩135B₩136B₩135B₩131B
Shareholders' equity₩135B₩131B₩130B₩128B₩124B₩126B₩125B₩122B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩4.9B₩3B₩12B₩837M−₩1.1B₩3.8B₩5.5B₩9.2B
Capital spending₩5.5B₩3.2B₩5B₩1.4B₩1.1B₩815M₩3.1B₩1.1B
Free cash flow−₩607M−₩235M₩7.4B−₩523M−₩2.2B₩3B₩2.3B₩8.1B
Dividends paid——₩0₩0————

Consolidated where available. Amounts in won.

Also known as: Yuyu Pharma / 유유제약 / 000220 / KRX:000220

Source: KRX statistical information